The BioPharmaDispatch analysis of the recently released annual PBS Expenditure and Prescriptions report has confirmed the challenge of assessing the scheme based on spending growth but confirms how it has effectively transformed into two programs.
News of the Day
Latest Video
New Stories
-
Budget update confirms how little is spent on new medicines
December 16, 2019 - - Latest News -
Upjohn's Gareth Richmond on creating the standalone entity
December 16, 2019 - - Latest News -
The PBS ending a 'topsy turvy' decade as two programs
December 16, 2019 - - Latest News -
These new lists are the 'targets'
December 16, 2019 - - Latest News -
Two countries and two major outcomes for the industry
December 16, 2019 - - Latest News -
Clinical trials: Competition across countries and companies
December 13, 2019 - - Latest News -
High in fees low on performance measures
December 13, 2019 - - Latest News